Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base ...

(RTTNews) - Neuronetics, Inc. (STIM), a neurohealth technology company, on Wednesday announced the publication of two significant peer-reviewed studies in the inaugural issue of the Transcranial ...

Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...

Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...

"The findings are significant, particularly for patients who have tried other treatments and not seen desired results," said Sabrina Segal, Ph.D., Director of Research at Family Care Center, who led ...

Neuronetics announced two publications highlighting the effectiveness of TMS for depression and the superiority of the PHQ-9 assessment tool. Neuronetics, Inc. announced the publication of two ...

New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation ...

NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...